The pharmaceutical world is observing a major shift in blood sugar therapy with the emergence of GLP-1 patches. These devices offer a potentially more convenient alternative to subcutaneous administrations of GLP-1 medications, minimizing the requirement of daily needle pokes. The approach delivers the drug directly through the epidermis, possib… Read More